Guaifenesin and Dextromethorphan Hydrobromide
- Product NDC
- 63868-391
- 11-digit product format
- 638680391
- Labeler code
- 63868
- Product ID
- 63868-391_0e0be98e-adad-4427-aac5-7d37736f0cdd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin and Dextromethorphan Hydrobromide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- CHAIN DRUG MARKETING ASSOCIATION INC
- Application
- NDA021620
- Marketing category
- NDA
- Marketing start
- 2017-12-10
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
- Active strength
- 1200 mg/1; mg/1
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63868-391 | I | Inactivated by FDA | 2026-08-17 | ||
| excluded package | package | 63868-391 | 63868-391-14 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63868-391-14 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63868-391-14 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63868-391-14 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63868-391-14 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63868-391-14 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63868-391-14 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63868-391-14 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63868-391-14 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63868-391-14 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63868-391-14 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63868-391-14 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63868-391-14 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 63868-391-14 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 63868-391-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 63868-391-14 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 63868-391-14 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63868-391-14 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63868-391-14 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 63868-391-14 | 8dfbde2a14a4… | c9ff85d89658… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021620-001 | MUCINEX DM | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | |
| N021620-002 | MUCINEX DM | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021620-001 | MUCINEX DM | 60MG;1.2GM | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2004-04-29 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021620-002 | MUCINEX DM | 30MG;600MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2004-04-29 | bb7c543d1eb4… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021620-001 | 6372252 | 2020-04-28 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021620-002 | 6372252 | 2020-04-28 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021620-002 | 7838032 | 2020-04-28 | Drug product | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021620-001 | 6372252 | 2020-04-28 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021620-002 | 6372252 | 2020-04-28 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021620-002 | 7838032 | 2020-04-28 | Drug product | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021620-001 | 6372252 | 2020-04-28 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021620-002 | 6372252 | 2020-04-28 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021620-002 | 7838032 | 2020-04-28 | Drug product | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021620-001 | 6372252 | 2020-04-28 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021620-002 | 6372252 | 2020-04-28 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021620-002 | 7838032 | 2020-04-28 | Drug product | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021620-001 | 6372252 | 2020-04-28 | Drug product | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021620-002 | 6372252 | 2020-04-28 | Drug product | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021620-002 | 7838032 | 2020-04-28 | Drug product | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021620-001 | 6372252 | 2020-04-28 | Drug product | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021620-001 | 6955821 | 2020-04-28 | U-685 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021620-001 | 7838032 | 2020-04-28 | Drug product | 2010-12-21 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021620-002 | 6372252 | 2020-04-28 | Drug product | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021620-002 | 6955821 | 2020-04-28 | U-685 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021620-002 | 7838032 | 2020-04-28 | Drug product | ea99ee380514… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4fe95224-f543-4dbb-9445-8cca122b48c8 | Product name | 1 | 20150609 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 106ff02a-57e1-4c4c-a307-fd582ff4e311 | Product name | 1 | 20150212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63868-391-14 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4125-a910-e053-dadaa90a0b85 | Guaifenesin 1200 mg & Dextromethorphan HBr 60 mg Extended-Release Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63868-391-14 | Guaifenesin and Dextromethorphan Hydrobromide | 2 in 1 CARTON | TABLET, EXTENDED RELEASE | 2 | 2 | |
| 63868-391-14 | Guaifenesin and Dextromethorphan Hydrobromide | 14 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 14 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucinex DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | 70987d06-d206-445f-bd0d-5e1345b8465c | 2026-06-15 | Warnings | 021620 NDA021620 |
| Mucinex DM Maximum Strength | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Reckitt Benckiser LLC | 588eddc1-fa30-41cc-8ed9-c01319ea21c6 | 2026-05-27 | Warnings | 021620 NDA021620 |
| Mucinex DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | A-S Medication Solutions | c04e67da-51f6-4ce3-9852-419d7b3a3742 | 2026-05-22 | Warnings | 021620 NDA021620 |
| Mucinex DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Sportpharm LLC | 8f4af6dd-6df4-49a7-98cf-655136923734 | 2026-02-26 | Warnings | 021620 NDA021620 |
| Mucinex DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Select Consumer Group | 3c9c8fb0-8a00-4b0f-e063-6394a90af632 | 2025-12-28 | Warnings | 021620 NDA021620 |
| MUCINEX DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | A-S Medication Solutions | fcaf1df9-b396-44f2-94ce-e46e80aba66c | 2025-10-01 | Warnings | 021620 NDA021620 |
| Mucinex DM, TRAVEL BASIX | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Lil' Drug Store Products, Inc. | c274b05c-8f05-4980-9a93-77affb322e57 | 2023-10-10 | Warnings | 021620 NDA021620 |
| Mucinex DM Maximum Strength | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | A-S Medication Solutions | 104b29ed-a377-4436-8e24-413c63579f2e | 2023-07-27 | Warnings | 021620 NDA021620 |
| Mucinex DM | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Navajo Manufacturing Company Inc. | 4226f394-f85e-45b1-8d5f-7cffb7dd492f | 2023-03-16 | Warnings | 021620 NDA021620 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1099074 | guaiFENesin 1200 MG / dextromethorphan HBr 60 MG 12HR Extended Release Oral Tablet | PSN | bf76e2f5-f2d0-4998-8ca7-969100fda42c | 2 |
| 1099074 | 12 HR dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG Extended Release Oral Tablet | SCD | bf76e2f5-f2d0-4998-8ca7-969100fda42c | 2 |
| 1099074 | dextromethorphan hydrobromide 60 MG / guaifenesin 1200 MG 12 HR Extended Release Oral Tablet | SY | bf76e2f5-f2d0-4998-8ca7-969100fda42c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 63868-391-14 | 63868039114 | 2 in 1 CARTON | Historical |